Tannenbaum Renee P's Form 4 filing
Cardiff Oncology, Inc. (CRDF) · filed Sep 19, 2022
- Accession no.
- 0001628280-22-025101
- Filed
- Sep 19, 2022
- Trade date
- Sep 15, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $17.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tannenbaum Renee PCIK 0001543174 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +6,400 | $1.72 | +$11,008 | 6,400 | Direct | |
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +3,600 | $1.72 | +$6,192 | 10,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.